PAVmed(PAVM) - 2024 Q4 - Earnings Call Presentation

Nasdaq: PAVM, PAVMZ Q4 2024 Business Update March 25, 2025 LISHAN AKLOG, MD Chairman & CEO DENNIS MCGRATH President & CFO Nasdaq: PAVM Nasdaq: LUCD Early Detection of Esophageal Precancer D I A G N O S T I C S Privately Held Digital Cancer Care Platform & Smart Vascular Access Port D I G I T A L H E A L T H Privately Held Incubator for MedTech Technologies, including PortIO, EsoCure, and CarpX M E D T E C H PMX Privately Held TBD T B D TBD Privately Held TBD T B D TBD Disclaimer ▪ This presentation may cont ...